Sentences with phrase «representing pharmaceutical companies»

Five trade groups representing pharmaceutical companies worldwide are urging their members to release more information about the clinical trials they conduct.

PhRMA, the trade association representing pharmaceutical companies, launched a new ad campaign in New York today as part of a multi-million dollar national effort to bolster the industry's image.

He represents pharmaceutical companies both large and small on a myriad of issues, as well as several universities in both patenting and licensing to outside investors.

Represented a pharmaceutical company in its Series B and Series C Preferred Stock financing in which $ 5M and $ 30M, respectively, was raised.

Represented pharmaceutical company in investigation by congressional committee of NIH grant - making practices.

Represented pharmaceutical company before the Federal Trade Commission with respect to a $ 9.5 billion acquisition.

Represented a pharmaceutical company in its Iran - U.S. Claims Tribunal claims against Iran for breach of contract under the UNCITRAL Rules.

Recent highlights include advising an airport on its strategy for managing land compensation claims; representing a pharmaceutical company in a dispute over the exercise of a commercial lease break clause relating to an office premises; and assisting a plc client with its strategy for dealing with compensation claims from residential property owners.

Our lawyers represented a pharmaceuticals company defending a US$ 12m claim for damages in a dispute about an allegedly defective medical device supplied under a Swiss law contract, referred to ICC arbitration in London.

Represented pharmaceutical company in a bench trial in the U.S. District Court for the District of Delaware over oncology product patents

Represented pharmaceutical companies in proceedings in the U.S. District Court for the Southern District of Indiana over cardiovascular product patents

Represented pharmaceutical company in False Claims Act qui tam action alleging improper marketing activities and wrongful termination, which resulted in a negotiated resolution.

Not exact matches

It has shown promise in metastatic melanoma, renal, and lung cancers — the last of which represents a huge opportunity for pharmaceutical companies (160,000 Americans are expected to die from lung cancer this year, compared with 10,000 from melanoma).

I typically represent technology companies in various sectors including web 2.0, mobile, semiconductors, EDA, security, software, networking, clean tech, digital media, video games, virtual worlds, medical devices and pharmaceuticals.

Antares Vision, a provider of serialization - based track and trace solutions for the pharmaceutical industry, held an open house celebrating the 10th anniversary of its North American operation to an audience of more than 100 guests representing pharma companies of all sizes.

When David Cameron and George Osborne lead British business on trade delegations overseas to bang the drum for UK plc, as well as seeing defence and pharmaceutical companies represented, I want to see music, film and other creative industries at the forefront.

Why did a bunch of Connecticut lobbyists and state contractors — representing special interests ranging from utilities to banks, pharmaceuticals and insurance companies — recently contribute about $ 28,000 to the re-election campaign of Virginia's Democratic attorney general, Mark Herring?

The Association of the German Pharmaceutical Industry represents approximately 310 German pharmaceutical companies and their interests with respect to issues such as drug licensing and reimbursement policy.

The conviction — on some, but not all, of the eight counts he was charged with — gives others in the sector even more reason to declare at full volume that Shkreli is not one of them, «and allows them to distance themselves from his predatory practices,» said Robert Mintz, a former federal prosecutor who is head of the white collar defense practice at McCarter & English, which represents branded pharmaceutical companies in a number of practice areas.

Considerations about patenting and intellectual property exist in industry, although the same is true for academia these days, says Alan Goldhammer, vice president of scientific and regulatory affairs for Pharmaceutical Research and Manufacturers of America (PhRMA), an organization that represents the country's leading pharmaceutical research and biotech companies.

Not only are all the major pharmaceutical companies represented in Singapore, but within the past three years Genentech, GlaxoSmithKline, Lonza, and Novartis announced decisions to build a total of five major biologics manufacturing facilities amounting to a US$ 1.5 billion investment.

Sanjay Gurunathan, representing a partnership of researchers, pharmaceutical companies and funders aimed at taking RV144 forward, said there had been some exciting post-trial analysis.

The Center would represent a hub to connect scientists and physicians at universities, research institutions, medical centers, and pharmaceutical companies.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

Patterson Belknap represents biotechnology, pharmaceutical and healthcare companies in a broad range of patent litigation matters, including patent infringement cases, PTO trial proceedings, patent licensing.

Company details show that American Friends of the GWPF is represented by Los Angeles lawyer, Paul Tosetti, who has handled several mergers of large pharmaceutical companies.

The US Chamber of Commerce's Board of Directors represent a wide range of companies with representation from energy companies, coal / oil / natural gas producers, pharmaceutical companies, chemical manufacturers, and the tobacco industry (see below).

With deep experience in product liability matters and class action litigation, including catastrophic injury and wrongful death cases, as well as consumer fraud, he represents national and international companies, including manufacturers of motor vehicles, power tools, pharmaceuticals, clothing, glass products, outdoor power equipment, and industrial machinery.

Oppenhoff & Partner's broad range of contentious work reflects an equally broad client roster, which includes investment and pharmaceutical companies, financial institutions and service providers, which the team frequently represents in corporate and post-M & A disputes, D&O liability proceedings and claims for damages.

Representing large pharmaceutical company in a consumer fraud class action against individuals and third - party payers seeking damages in excess of $ 50 million.

We represent borrowers in most sectors of the economy, including real estate development, technology, pulp and paper, mining, manufacturing, pharmaceutical, distribution, entertainment, construction, importers, exporters and foreign companies investing or establishing a presence in Canada.

Represent major pharmaceutical company in federal investigation into sales and marketing practices.

Represented multinational pharmaceutical company in product liability litigation in courts across the country and before the Judicial Panel on Multidistrict Litigation.

She represents a consortium of multinational pharmaceutical companies manufacturing asthma therapies that rely on propellants subject to regulation under the Montreal Protocol and Kyoto Protocol.

As one of the nation's leading lawyers in the emerging field of state unclaimed property laws, John devotes a substantial part of his practice to representing and advising a variety of manufacturers, retailers, distributors, financial institutions, pharmaceutical companies, telecommunications and transportation companies, utilities, service providers and other types of businesses on complex multi-state unclaimed property audits, litigation, voluntary disclosure agreements and transactional issues.

She has successfully represented a number of leading semiconductor and pharmaceutical companies in some of their most important and challenging intellectual property matters.

Represented a biotechnology company focused on novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes, in negotiating a license into the company relating to its core technology, and represent the company with regard to the creation and maintenance of its stock option plan and other general legal matters.

A law review editor and cum laude graduate of Northwestern School of Law at Lewis & Clark College and a magna cum laude graduate of University of Maryland Baltimore County, Steve began his career working alongside Joe C. Freeman Jr., a legendary Atlanta trial lawyer known for defending the Eli Lilly pharmaceutical company in suicide cases, representing JCPenney in flammable pajama cases and serving as national counsel for Chrysler.

Specializing in producing TV campaigns for lawyers who represent those harmed by pharmaceutical and medical device companies, Mr. Nober says that the economics of medical legal advertising is impressive.

John has previously represented the State of South Carolina Department of Health and Human Services and South Carolina Employee Insurance Program in lawsuits brought against a number of pharmaceutical companies in the Average Wholesale Price litigation.

Mark Ridgway Qualified: 2004 Made partner: 2015 Key cases: Representing Pfizer group company Warner - Lambert in its pan-European enforcement efforts in relation to its second medical use patent for its blockbuster drug Lyrica; acted for Novartis Pharmaceuticals on a multijurisdictional biotechnological patent dispute relating to the blockbuster drug Lucentis; advising Blackberry on several high profile, global patent disputes.

Sindhu Daniel manages the firm's Pharmaceutical Litigation Group and has a passion for representing people harmed by big pharmaceutical companies which have marketed their products as safe when they are not or have otherwise misrepresented the efficacy and toxicity of their medical commodities.

He represents generic pharmaceutical companies in ANDA litigation.

Represented Janssen Pharmaceuticals, Johnson & Johnson and related companies in a 2013 global resolution of multiple DOJ investigations, including the negotiation and settlement of False Claims Act; Food, Drug & Cosmetic Act; and related allegations.

He represents clients in a range of matters, including antitrust, securities, intellectual property, class actions and internal investigations and his clients include media companies, pharmaceutical companies, computer technology companies, energy companies, investment and commercial banks, hedge funds and private equity firms, independent audit committees, members of Congress and the City of New York.

He represents companies, officers, directors, investment advisors, broker - dealers, placement agents and others in virtually every industry, including technology hardware and software, financial services, medical devices, pharmaceuticals, manufacturing and energy.

He has extensive experience in representing a major media company, financial institutions, brand name pharmaceutical manufacturers, accounting firms, law firms, and a variety of other companies and professionals in federal and state litigation, including in matters involving antitrust law, securities law, corporate governance, pharmaceutical pricing, contract disputes, accountants liability, legal malpractice and communications law.

We have represented plaintiffs in Bextra lawsuits and will continue to protect consumers by filing individual claims and class action and multidistrict lawsuits against negligent pharmaceutical companies.

He also represents pharmaceutical and bio-tech companies as plaintiffs and defendants in international and domestic arbitrations and litigation regarding commercial practices and pricing, milestones, contracts, and partnerships.